The pharmaceutical drug "Bellgin", instructions for use reports, is a combined drug used in gastroenterology. One tablet contains two hundred and fifty milligrams of metamizole sodium, a similar amount of benzocaine, one hundred milligrams of sodium bicarbonate, fifteen milligrams of belladonna extract (thick). These active components of the drug not only complement, but also enhance the effect of each other.
The drug Bellalgin (instructions for use include this information) produces a moderate antispasmodic effect, can slow intestinal motility, reduce acidity and secretion of gastric juice, and also have a local anesthetic and analgesic effect. The drug is effective in eliminating pain in the epigastric region (also with a hyperacid state).
The Bellalgin medication for use recommends using for symptomatic short-term treatment both adolescents over fourteen and adult patients suffering from intestinal colic and gastralgia, concomitant hyperacid gastritis, gallstone disease, ulcerative lesions of the duodenum and / or stomach, spastic colitis. It is allowed to use the drug in question as part of a comprehensive treatment.
The drug "Bellalgin." Instructions for use, dosage
The specified drug is taken orally. The Bellalgin medication (tablets) should not be crushed, divided. When taking it, it is necessary to drink it with a sufficient amount of clean water. It is recommended to use the drug immediately after eating. As a rule, this medication is not prescribed for long-term treatment. The duration of therapy and optimal dosages are determined solely by the attending physician. The following are averaged data:
For complaints of stomach pain, adult patients are shown one tablet a maximum of three times a day. You should not take more than three tablets at a time and more than ten during the day.
It is noted that if the patient’s condition does not improve after three days from the start of treatment, he should be assigned a different regimen of Bellalgin drug therapy.
The instructions for use report that the pharmaceutical product in question can cause the development of the following undesirable consequences: agranulocytosis (extremely rare), leukopenia, tachycardia, constant thirst, loose stools / constipation, dry mouth. From the side of the central nervous system, disorders such as insomnia, headaches, dizziness, overexcitation or, conversely, weakness, apathy are not excluded. In addition, a rash, a feeling of itching, and hives may develop on the skin.
The medication in question is not prescribed for severe failures in the functioning of the liver or kidneys, glaucoma, impaired functioning of the hematopoiesis system, benign prostatic hyperplasia. The drug is also contraindicated in patients under the age of fourteen and pregnant women.
An increase in the toxic effect produced by this medication has been established when used together with oral contraceptives, non-steroidal anti-inflammatory drugs and tricyclic antidepressants.
In case of an overdose, gastric lavage, symptomatic treatment, and the use of enterosorbents are indicated. Therapy should be carried out under the supervision of a specialist (in a hospital).
The drug goes on sale in blister packs of ten pieces each.
Do not expose tablets to direct sunlight.